Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Eksjo – page 3

45 clinical trials in Eksjo, Sweden. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Eksjo at a glance
45
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

45 trials in Eksjo

Open in trial search

Colorectal cancer

Not yet recruiting

Study on Acetylsalicylic Acid for Colorectal Cancer Patients with PI3K Pathway Mutations

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Karolinska Institutet

Malignant melanoma

Not yet recruiting

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Melanoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC

Cardiac failure+1

Not recruiting

Study on Sodium Zirconium Cyclosilicate for Improving Heart Failure Treatment in Patients with High-Risk Hyperkalemia

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Zirconium Cyclosilicate
  • Sponsor:Vastra Gotalandsregionen

Study of datopotamab deruxtecan with or without durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:AstraZeneca AB

Breast cancer+1

Not recruiting

Study of PF-07220060 and Letrozole for Adults with HR-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Pfizer Inc.

Breast cancer+1

Not recruiting

Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Pfizer Inc.

Breast cancer+1

Not recruiting

Study of Tucatinib and Ado-Trastuzumab Emtansine for Patients with Advanced HER2+ Breast Cancer

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Tucatinib
  • Sponsor:Seagen Inc.

Study Comparing Gemcitabine and Mitomycin for Patients with Intermediate Risk Non-Muscle Invasive Bladder Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:Region Skane

Comparison of dapagliflozin versus metformin treatment in patients with early stage type 2 diabetes to evaluate survival and complications

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin Propanediol
  • Sponsor:Uppsala University

Study of spironolactone and eplerenone in patients with heart failure with preserved ejection fraction (HFpEF)

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Altizide
  • Sponsor:Region Uppsala

Hypercholesterolaemia

Not recruiting

Study on Evolocumab for Reducing Cardiovascular Events in Patients with Acute Myocardial Infarction

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Facial paresis

Not recruiting

Study on Betamethasone Sodium Phosphate for Treating Acute Facial Nerve Palsy in Children

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years
  • Sponsor:Region Dalarna

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Eksjo

What the registry says about research in the country

01 Women's Health & Obstetrics

Research focusing on advancing methods in labor induction and ovarian cancer treatment. Studies examine outpatient versus inpatient labor induction protocols and evaluate biomarker responses in cancer therapy.

  • Labor Management Innovation
  • Gynecologic Oncology

Novel approaches in outpatient care delivery and cancer treatment optimization are being investigated to improve patient outcomes.

02 Orthopedics & Joint Health

Innovative research exploring infection prevention in hip arthroplasty through the use of antibiotic-impregnated bone grafts, aiming to enhance surgical outcomes and reduce complications.

  • Joint Replacement
  • Infection Prevention

These studies focus on developing better strategies to prevent prosthetic joint infections and improve patient recovery.

03 Urology & Nephrology

Comprehensive studies on bladder cancer treatment and management of kidney disease with concurrent conditions. Research includes evaluation of various therapeutic approaches for non-muscle invasive bladder cancer.

  • Cancer Treatment
  • Renal Disease Management

Clinical investigations aim to optimize treatment protocols and improve patient care in complex urological conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.